Pihlajalinna (HLSE:PIHLIS) Stock Faces EPS Collapse That Tests Bullish Earnings Growth Narrative

Pihlajalinna Oyj (HLSE:PIHLIS) has reported Q2 2026 revenue of €136.7 million with basic EPS of €0.01, alongside trailing twelve month EPS of €1.06 on revenue of €575.1 million and net income of €24.5 million. The company has seen quarterly revenue move from €175.5 million in Q2 2025 to €136.7 million in Q2 2026, while basic EPS shifted from €0.39 to €0.01 over the same period. This sets up a quarter where investors are likely to focus closely on how margins are holding up against the longer term earnings growth profile.

See our full analysis for Pihlajalinna Oyj.

Next up is how these latest results line up against the widely followed growth, value and risk narratives that have built around Pihlajalinna Oyj, and where the new numbers start to challenge those stories.

Curious how numbers become stories that shape markets? Explore Community Narratives

TTM profitability cools to 4.3% margin

• Over the last twelve months, Pihlajalinna Oyj generated €575.1 million in revenue and €24.5 million in net income, which works out to a 4.3% net margin compared with 5.0% a year earlier.
• What stands out for a bullish view is that earnings are forecast to grow 16.1% per year after five year historical earnings growth of 19.1%. The latest quarterly net income was only €0.1 million, which can prompt bulls to ask how that growth view sits alongside a lower trailing margin and a recent run of quarterly net income between €0.1 million and €12.1 million.

Revenue growth trails Finnish market

• Revenue growth for Pihlajalinna is forecast at 2.8% per year compared with a 4.7% per year forecast for the wider Finnish market. Trailing revenue of €575.1 million sits below earlier twelve month levels of up to €702.1 million.
• Bears argue that slower top line momentum can limit operating flexibility, and the figures here give them some support because revenue growth expectations sit below the broader market and the current 4.3% net margin is lower than the 5.0% level reported a year earlier. Together, these factors frame a business where profitability is tied to modest revenue growth and a margin profile that has eased over the past year.

Valuation screens cheap versus DCF fair value

• The current share price of €10.26 is well below the provided DCF fair value of €28.47 and sits alongside a trailing P/E of 9.4x versus 20.2x for the broader European Healthcare industry and 59.4x for peers.
• Consensus narrative style thinking that low multiples alone tell the whole story is challenged a bit by the risk flags here. The same data that points to apparent value also highlights an unstable dividend history and a high level of debt, so investors weighing the 9.4x P/E relative to peers and the gap to DCF fair value are likely to consider those balance sheet and payout risks alongside the forecast 16.1% earnings growth.

To see how other investors are interpreting this mix of slower revenue growth, softer margins and discounted valuation for Pihlajalinna Oyj, spend a few minutes with the 📊 Read the what the Community is saying about Pihlajalinna Oyj.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Pihlajalinna Oyj's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

With mixed signals across Pihlajalinna Oyj's growth, margins and valuation, the next move really comes down to your own judgment. Take a closer look at the numbers, weigh the concerns against the potential, and review the 3 key rewards and 2 important warning signs

See What Else Is Out There

Pihlajalinna Oyj is working with softer margins, modest revenue expectations and balance sheet concerns that include high debt and an unstable dividend record.

If you want ideas that put financial strength and steadier income potential front and center, take a few minutes to scan the 453 dividend fortresses as a starting point.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com